Gå direkt till innehåll

Kategorier: swedish state

  • Above from left: Jan Pilebjer, business developer GU Ventures, and Martin Olovsson, CEO OnDosis. Below, from left: Magnus Björsne, CEO AstraZeneca BioVentureHub, and Klementina Österberg, CEO GU Ventures.

    Introducing OnDosis, a new life science company

    Based on innovative technology developed by AstraZeneca, OnDosis is a new, Gothenburg-based, life science company with the mission to simplify dosing and enable personalised administration of medicines by connecting medicines, devices and digital health to benefit patients. AstraZeneca and GU Ventures have founded OnDosis together with entrepreneurial CEO, Martin Olovsson.